Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

RABIES VACCINE, VETERIN

Active
SPE2DP-26-T-4904Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract is for the procurement of IMRAB 3, a thimerosal-free, killed-virus veterinary rabies vaccine designed for three-year protection. The item is supplied by Boehringer Ingelheim Animal Health USA under part number 10391 and is issued in packages of 50 units. Strict storage requirements are mandated, requiring refrigeration between 2 and 8 degrees Celsius and a prohibition against freezing. The product has a non-extendable shelf life of 24 months and is regulated by the FDA. The order consists of one package under solicitation SPE2DP-26-T-4904, with delivery required within 84 days. All shipments must adhere to Medical Marking Standard No. 1 and DLA packaging requirements, with inspection and acceptance occurring at the destination. The contract is managed by the Department of Defense Medical Supply Chain Pharma FSA and includes specific technical and quality requirements as outlined in the DLA master list.

General Info

Procurement of one package of IMRAB 3 rabies vaccine from Boehringer Ingelheim.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

ATTN CL VIII MED REQ PROCES ACT, APO, AE, 09227-0000, USA

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4904.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA
Contacts

Full Description

Show more
RABIES VACCINE,VETERINARY
RABIES VACCINE, VETERINARY
.
THIMEROSAL FREE RABIES VACCINE; VIRUS CONDITION: KILLED; 3-YEAR VACCINE;
"IMRAB 3" 3 YEAR VACCINE; USE ENTIRE CONTENTS WHEN FIRST OPEN.
.
UNIT OF ISSUE: PACKAGE (PG) OF 50EA
.
STORE REFRIGERATED BETWEEN 2-8 DEGREES C. DO NOT FREEZE.
.
SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1
HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/
.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
.
..
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
BOEHRINGER INGELHEIM ANIMAL HEALTH USA 50614 P/N 10391
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018195585 0001 PG 1.000
SPE2DP-26-T-4904
SECTION B
PR: 7018195585 PRLI: 0001 CONT’D
NSN/MATERIAL:6509015265369
DELIVERY (IN DAYS):0084
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6509-01-526-5369 Quantity: 1 PG Purchase Request: 7018195585QTY: 1 Delivery: 84 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
36E79726R0032 Lisinopril Tablets (VA-27-00004937)
Solicitation # 36E79726R0032
The Department of Veterans Affairs is conducting an unrestricted procurement under solicitation 36E79726R0032 to secure an uninterrupted source of supply for Lisinopril Tablets. This contract supports multiple federal health agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers, with distribution managed through the VA and DOD Pharmaceutical Prime Vendor Programs. The award will be granted to a single responsible offeror for a base period of one year, with four pre-priced one-year option periods. The procurement is issued in a commercial item format in accordance with FAR Part 12, with a tentative solicitation release date of September 3, 2026, and a response deadline of September 24, 2026. The scope of work includes the supply of Lisinopril tablets in various strengths ranging from 2.5mg to 40mg, with specific annual quantity requirements for various bottle sizes. Strict packaging and labeling standards are mandated, requiring a unique NDC number and the exact drug name on the label. For specific unit-of-use packaging, bottles must be cylindrical with a minimum 120cc volume and a 5.75 inch circumference to accommodate a 5.25 by 2 inch label. Additionally, these bottles must feature a safety cap that is either convertible or deshellable. The contractor's label must be the only label on the product and must allow VA labels to adhere securely on top. All proposals and communications are handled electronically via SAM.gov.
Nac Pharmaceuticals (36E797)

POSTED

about 22 hours ago

DEADLINE

in 20 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency